LAS VEGAS, April 01, 2022 (GLOBE NEWSWIRE) -- Healthy Extracts Inc. (OTCQB: HYEX), a leading innovator of clinically proven plant-based…
Presentations highlight potential of losmapimod to slow or stop progression of FSHD Company on track to initiate Phase 3 REACH…
Two poster presentations highlight Phase 1 data for LP352 in healthy volunteersSAN DIEGO, April 01, 2022 (GLOBE NEWSWIRE) -- Longboard…
ANAHEIM, CA, April 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of…
MIAMI, April 01, 2022 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on efficiently…
VANCOUVER, British Columbia, April 01, 2022 (GLOBE NEWSWIRE) -- Simply Better Brands Corp. (the "Company" or “Simply Better Brands”) (TSX…
PRINCETON, N.J., April 01, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will…
FLORHAM PARK, N.J., April 01, 2022 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused…
LAKEWOOD Ranch, Fla., April 01, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – Brain Scientific (OTCQB: BRSF), an innovative company focusing…
Results from Phase 1b/2a study of efzofitimod in pulmonary sarcoidosis patients demonstrate safety and dose dependent trends of improvement compared…